| Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma JM Logue, E Zucchetti, CA Bachmeier, GS Krivenko, V Larson, D Ninh, ... Haematologica 106 (4), 978, 2021 | 175 | 2021 |
| Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma MD Jain, H Zhao, X Wang, R Atkins, M Menges, K Reid, K Spitler, ... Blood, The Journal of the American Society of Hematology 137 (19), 2621-2633, 2021 | 165 | 2021 |
| Tumor microenvironment composition and severe cytokine release syndrome (CRS) influence toxicity in patients with large B-cell lymphoma treated with axicabtagene ciloleucel R Faramand, M Jain, V Staedtke, H Kotani, R Bai, K Reid, SB Lee, ... Clinical Cancer Research 26 (18), 4823-4831, 2020 | 57 | 2020 |
| Patterns and predictors of failure in recurrent or refractory large B-cell lymphomas after chimeric antigen receptor T-cell therapy NB Figura, TJ Robinson, AJ Sim, X Wang, B Cao, JC Chavez, BD Shah, ... International Journal of Radiation Oncology* Biology* Physics 111 (5), 1145-1154, 2021 | 35 | 2021 |
| Pathological and survival outcomes associated with variant histology bladder cancers managed by cystectomy with or without neoadjuvant chemotherapy A Hajiran, M Azizi, AM Aydin, L Zemp, CC Peyton, J Dhillon, S Nealon, ... The Journal of urology 205 (1), 100-108, 2021 | 29 | 2021 |
| Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers ES Tan, B Cao, J Kim, TE Al‐Toubah, R Mehta, BA Centeno, RD Kim Cancer 127 (8), 1293-1300, 2021 | 25 | 2021 |
| Long noncoding RNA, LINC00460, as a prognostic biomarker in head and neck squamous cell carcinoma (HNSCC) R Chaudhary, X Wang, B Cao, J De La Iglesia, J Masannat, F Song, ... American Journal of Translational Research 12 (2), 684, 2020 | 19 | 2020 |
| A phase I trial of trametinib in combination with sorafenib in patients with advanced hepatocellular cancer R Kim, E Tan, E Wang, A Mahipal, DT Chen, B Cao, F Masawi, ... The oncologist 25 (12), e1893-e1899, 2020 | 18 | 2020 |
| Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy DK Lester, C Burton, A Gardner, P Innamarato, K Kodumudi, Q Liu, ... Nature cancer 4 (2), 222-239, 2023 | 17 | 2023 |
| PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients Y Kim, D Kim, B Cao, R Carvajal, M Kim BMC bioinformatics 21, 1-21, 2020 | 17 | 2020 |
| Efficient gradient boosting for prognostic biomarker discovery K Li, S Yao, Z Zhang, B Cao, CM Wilson, D Kalos, PF Kuan, R Zhu, ... Bioinformatics 38 (6), 1631-1638, 2022 | 14 | 2022 |
| Multi-resolution classification of exhaled aerosol images to detect obstructive lung diseases in small airways J Xi, W Zhao, JE Yuan, B Cao, L Zhao Computers in Biology and Medicine 87, 57-69, 2017 | 13 | 2017 |
| Multi-dimensional flow cytometry analyses reveal a dichotomous role for nitric oxide in melanoma patients receiving immunotherapy SK Garg, MJ Ott, AGM Mostofa, Z Chen, YA Chen, J Kroeger, B Cao, ... Frontiers in immunology 11, 164, 2020 | 9 | 2020 |
| Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC). E Wang, DW Kim, A Mahipal, DT Chen, B Cao, F Masawi, RD Kim Journal of Clinical Oncology 37 (4_suppl), 431-431, 2019 | 8 | 2019 |
| Telemedicine adoption in an NCI-designated cancer center during the COVID-19 pandemic: a report on patient experience of care KB Patel, AA Tabriz, K Turner, BD Gonzalez, LB Oswald, HSL Jim, ... Journal of the National Comprehensive Cancer Network 21 (5), 496-502. e6, 2023 | 4 | 2023 |
| Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma NI Khushalani, M Vassallo, JD Goldberg, Z Eroglu, Y Kim, B Cao, ... Journal for Immunotherapy of Cancer 10 (11), 2022 | 4 | 2022 |
| A simple test‐based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study T Hembree, O Theou, S Thirlwell, RR Reich, B Cao, M Sehovic, M Syed, ... Cancer Medicine 10 (17), 5765-5774, 2021 | 4 | 2021 |
| CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response OS Akhtar, B Cao, X Wang, P Torka, M Al-Jumayli, FL Locke, CL Freeman Blood Advances 7 (19), 5937-5940, 2023 | 2 | 2023 |
| A subnetwork-based framework for prioritizing and evaluating prognostic gene modules from cancer transcriptome data B Cao, KB Patel, T Li, S Yao, CH Chung, X Wang iScience 26 (2), 2023 | 2 | 2023 |
| The Impact of the Affordable Care Act on Insurance Coverage and Stage Among Head and Neck Squamous Cell Carcinoma Patients KB Patel, S Shabani, T Padhya, B Cao, X Wang, K Turner, AC Nichols, ... Journal of Health Care for the Poor and Underserved 33 (3), 1322-1336, 2022 | 2 | 2022 |
